Pharma

By Jonah Comstock September 23, 2014
Roche subsidiary Genentech is no stranger to online patient communities -- the pharma company signed a five-year data access deal with online patient community company PatientsLikeMe in April. At the Health 2.0 conference in Santa Clara this week, Genentech product development leader Joling Mew spoke about the ways that Genentech has worked with PatientsLikeMe, and other online patient...
By Jonah Comstock September 23, 2014
Janssen Healthcare Innovation, a Johnson and Johnson company, is introducing a provider-facing component to its Care4Today mobile health manager application, the company announced from the stage at Health 2.0 in Santa Clara, California today. "It’s called the patient dashboard, and it allows provider to manage patient adherence in real time," Janssen marketing director Fran Devlin told...
By Jonah Comstock September 3, 2014
Sanofi Diabetes, a division of Sanofi-Aventis, has launched a new mobile game for iOS and Android phones in the United Kingdom. The game, called Mission T1D, is meant to be educational, to teach children as well as their parents, caregivers, and friends about Type 1 diabetes. "Children with diabetes and their families face many challenges in their daily lives as they care for a very complex life-...
By Jonah Comstock August 28, 2014
Bayer HealthCare, a German pharmaceutical company, has underscored pharma's growing interest in mobile health by starting a new health accelerator. Grants4Apps, which started last year as a crowdsourcing initiative, was releaunched as an accelerator at an event earlier this week. The commitment on Bayer's part is pretty significant: they'll be offering 50,000 euro (about $65,000) to each of the...
By Jonah Comstock August 19, 2014
While Novartis' recent partnership with Google and its longtime relationship with Proteus have indicated that the pharma company has an interest in digital health, a page on the company's website, added this summer, lays out its broad vision and explicit interest in mobile health specifically. The company even has a mobile health strategy lead, Michele Angelaccio, who holds the title of Associate...
By Jonah Comstock August 12, 2014
Iowa-based TelePharm has raised $2.5 million from venture capitalist John Pappajohn and Bruce Rastetter, president of the Iowa state Board of Regents. The company, which is also a member of the Rock Health accelerator, will use the funds to scale its business, which connects pharmacists to one another and to patients via cloud-based mobile apps. "I think the pharmacists’ position is changing,"...
By Aditi Pai August 7, 2014
Haifa, Israel-based MediSafe added a birth control pill tracking feature to its medication adherence app this week. MediSafe, which was in Microsoft's Tel Aviv accelerator, offers a cloud-based app system for medication adherence. Patients using MediSafe get a reminder to take their meds on their Android or iPhone app, and are then prompted to record doses when they take them. If they don’t...
By Aditi Pai August 5, 2014
Proteus Digital Health Proteus Digital Health published a paper on its ingestible sensor that explains the design of the sensor, the safety tests Proteus completed, and the clinical trials Proteus conducted with 412 patients who used the system over 5,656 days. The Proteus digital medicine platform is a medication management and adherence system that includes unique measurement tools, like...
By Brian Dolan July 29, 2014
Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That brings Proteus' latest round of funding -- its seventh -- to $172 million. By our count the company's total known funding is now close to $400 million, which makes it one of the most-funded, private...
By Jonah Comstock July 28, 2014
Cambridge, Massachusetts-based flexible electronics company MC10 has embarked on its first public partnership with a pharmaceutical company, Belgium-based UCB. Although many of the details remain undisclosed, the companies have announced that UCB will use MC10's BioStamp technology to pursue new therapies for neurological disorders. "They’re going to combine our devices with their work to...

Editor's Pick